Skip to main content

Prothena Corp Public Ltd Co

PRTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001559053

In the last 90 days, Prothena Corp Public Ltd Co insiders filed 6 open-market purchases and 2 sales; 187 institutions reported holding it in 13F filings for Q2 2026, worth $462.7M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Prothena Corp Public Ltd Co changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of PRTA: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1864187+5
Shares47.3M325.5K47.3M+304.2K (+0.6%)
Value$459.5M$3.16M$462.7M+$6.28M (+1.4%)

4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Prothena Corp Public Ltd Co at the end of Q2 2026 but not at the end of Q1 2026.

Sold out (23)

Institutions that held Prothena Corp Public Ltd Co at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (4)

Institutions that held Prothena Corp Public Ltd Co at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRTA in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Deeter Investments LLP300,000$2.92M
Skopos Labs, Inc.14,993$145.7K
CWM, LLC10,276$99.9K
Evelyn Partners Investment Management LLP199$1.93K